Summary: Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget immune cells to tumor cells. It is designed for the research of B cell lymphoma therapy.https://www.creative-biolabs.com/bsab/symbolsearch-b%2520cell%2520lymphoma%2520bcl1%2520idiotype%2520%2526%2520cd64.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
